Top Story

Insulin resistance increases CVD risk in postmenopausal women without diabetes

May 6, 2015

Postmenopausal women with measures of insulin resistance or impaired fasting glucose have an increased risk for cardiovascular disease even if they do not have diabetes, according to research in Circulation: Cardiovascular Quality and Outcomes.

In a large, multi-ethnic prospective cohort study of more than 15,000 postmenopausal women, researchers also observed that measuring insulin resistance through insulin levels, homeostasis model assessment-insulin resistance (HOMA-IR), glucose and the ratio of triglycerides to HDL did not improve disease risk prediction beyond traditional CVD risk factors.

In the Journals

C-peptide, islet autoantibodies may predict severe hypoglycemia risk

May 6, 2015
During intensification of type 2 diabetes treatment, the risk for severe hypoglycemia may be predicted by the biomarkers C-peptide and islet autoantibodies, according to…
Meeting News Coverage

Survival worse in lung recipients of donors with diabetes

May 6, 2015
SEATTLE — Patients who received a single lung transplantation from a donor with diabetes were at a significantly increased risk for mortality compared with lung…
In the Journals

Mixed experiences, challenges common 6 years after gastric bypass surgery

May 6, 2015
Patients who undergo laparoscopic gastric bypass surgery report negative effects in the years after the procedure, including personality changes, social challenges…
In the Journals

Insulin resistance increases CVD risk in postmenopausal women without diabetes

May 5, 2015
Postmenopausal women with measures of insulin resistance or impaired fasting glucose have an increased risk for cardiovascular disease even if they do not have diabetes…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
VIDEO: Diet and lifestyle changes are key to managing PCOS

VIDEO: Diet and lifestyle changes are key to managing PCOS

April 27, 2015
PHILADELPHIA — Angela Grassi, MS, RD, LDN, founder of the PCOS Nutrition Center in Philadelphia, explains that…
More »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Current Issues
View the Current Issues
morganatic-roan